¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"T-Cell Antigen Receptor Specificity"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
complement receptor
º¸Ã¼¼ö¿ëü
corpuscular receptor
¼Òü¼ö¿ëü
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cholinergic receptor
Äݸ°¼ö¿ëü
distance receptor
¿ø°Ý¼ö¿ë±â
dominant receptor
¿ì¼º¼ö¿ëü
early receptor potential
Á¶±â¼ö¿ëüÀüÀ§, Á¶±â½Ã°¢¼¼Æ÷ÀüÀ§
estrogen receptor
¿¡½ºÆ®·Î°Õ¼ö¿ëü
free receptor
À¯¸®¼ö¿ëü
gustatory receptor
¹Ì°¢¼ö¿ë±â
H1 receptor
H1¼ö¿ëü
H2 receptor
H2¼ö¿ëü
heat receptor
¿¼ö¿ë±â
hairy skin receptor
ÅÐÇǺμö¿ë±â
histamine receptor
È÷½ºÅ¸¹Î¼ö¿ëü
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
9
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
recombinant antigen
ÀçÁ¶ÇÕÇ׿ø
sequestered antigen
°Ý¸®Ç׿ø
somatic antigen
ü¼¼Æ÷Ç׿ø, ±ÕüÇ׿ø
surface antigen
Ç¥¸éÇ׿ø
tumor antigen
Á¾¾çÇ׿ø
antigen excess
Ç׿ø°úÀ×
antigen presentation
Ç׿øÀü´Þ
antigen-antibody reaction
Ç׿øÇ×ü¹ÝÀÀ
antigen-binding site
Ç׿ø°áÇÕºÎÀ§
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
type specificity
ÇüƯÀ̼º
adrenergic receptor
¾Æµå·¹³¯¸°¼ö¿ëü
androgen receptor
¾Èµå·Î°Õ¼ö¿ëü
receptor autoradiography
¼ö¿ëüÀÚ°¡¹æ»ç¼±¼ú
beta-adrenergic receptor kinase
º£Å¸¾Æµå·¹³¯¸°¼º¼ö¿ëüÀλêÈÈ¿¼Ò
receptor binding
¼ö¿ëü°áÇÕ
receptor blocker
¼ö¿ëüÂ÷´ÜÁ¦
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cholinergic receptor
Äݸ°¼ö¿ëü
cold receptor
³Ã°¢¼ö¿ëü
complement receptor
µµ¿òü¼ö¿ëü, º¸Ã¼¼ö¿ëü
corpuscular receptor
¼Òü¼ö¿ëü
receptor cell
¼ö¿ëü¼¼Æ÷
distance receptor
(¢¡teleceptor) ¿ø°Ý¼ö¿ëü
dominant receptor
¿ì¼º¼ö¿ëü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
Kinesthetic receptor
¿îµ¿(ê¡ÔÑ)(°¨(Êï))°¢¼ö¿ëü(ÊÆáôé»ô÷)
NMDA receptor
¿£¾Úµð¿¡ÀÌ ¼ö¿ëü
T cell receptor
T¼¼Æ÷[Ç׿ø]¼ö¿ëü
T cell receptor gene
T¼¼Æ÷[Ç׿ø]¼ö¿ëü À¯ÀüÀÚ
acetylcholine receptor
¾Æ¼¼Æ¿Äݸ° ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
acetylcholine receptor
¾Æ¼¼Æ¿Äݸ°¼ö¿ëü
acetylcholine receptor antibody
¾Æ¼¼Æ¿Äݸ°¼ö¿ëüÇ×ü
acetylcholine receptor antibody assay
¾Æ¼¼Æ¿Äݸ°¼ö¿ëü Ç×Ã¼ÃøÁ¤
alpha-adrenal receptor antagonist
¾ËÆÄ ¾Æµå·¹³¯¸°¼ö¿ëüÂ÷´ÜÁ¦
alpha-adrenergic receptor
¾ËÆÄ-¾Æµå·¹³¯¸°¼ö¿ëü.
alpha-adrenergic receptor
¾ËÆÄ¾Æµå·¹³¯¸°¼ö¿ëü
androgen receptor
³²¼ºÈ£¸£¸ó ¼ö¿ëü
homing receptor
±Í¼Ò¼ö¿ëü
immunoglobulin receptor
¸é¿ª±Û·ÎºÒ¸° ¼ö¿ëü
insulin receptor
Àν¶¸°¼ö¿ëü(áôé»ô÷).
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
type specificity
ÇüƯÀ̼º
capsular antigen =K. antigen
Çù¸·Ç׿ø(¡ù÷ê«).
acetylcholine receptor
¾Æ¼¼Æ¿Äݸ°¼ö¿ëü
acetylcholine receptor
¾Æ¼¼Æ¿Äݸ° ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
acetylcholine receptor antibody
¾Æ¼¼Æ¿Äݸ°¼ö¿ëüÇ×ü
acetylcholine receptor antibody assay
¾Æ¼¼Æ¿Äݸ°¼ö¿ëü Ç×Ã¼ÃøÁ¤
adrenergic receptor
¾Æµå·¹³¯¸°¼º ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â,°¨¼öü)
alpha-adrenal receptor antagonist
¾ËÆÄ ¾Æµå·¹³¯¸°¼ö¿ëüÂ÷´ÜÁ¦
alpha-adrenergic receptor
¾ËÆÄ-¾Æµå·¹³¯¸°¼ö¿ëü.
alpha-adrenergic receptor
¾ËÆÄ¾Æµå·¹³¯¸°¼ö¿ëü
androgen receptor
³²¼ºÈ£¸£¸ó ¼ö¿ëü
benzodiazepine receptor agonists(s)
º¥Á¶´ÙÀ̾ÆÁ¦ÇÉ ¼ö¿ëü ÀÛ¿ëÁ¦
benzodiazepine receptor antagonist(s)
º¥Á¶´ÙÀ̾ÆÁ¦ÇÉ ¼ö¿ëü ±æÇ×Á¦
benzodiazepine receptor(s)
º¥Á¶´ÙÀ̾ÆÁ¦ÇÉ ¼ö¿ëü
beta adrenergic receptor
º£Å¸¾Æµå·¹³¯¸°¼º ¼ö¿ëü(¼ö¿ë±â, °¨¼öü)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½